Almac commits to be
net zero by 2045
Find out more in our Corporate Social Responsibility Report 2022
Learn more
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
6500+
Employees globally
54%
Contributed to over half of approved NMEs in the last 5 years
50+
Years’ experience
25
Work with top 25 BioPharma companies
18
Facilities globally
Latest from Almac
Partnering to advance human health
Explore our LocationsPharmaceutical Development & Manufacturing Services
Pharmaceutical Development & Manufacturing Services
Almac recognises that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialised drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation.
Find out more
Diagnostic Services
Diagnostic Services
Almac Diagnostic Services is our precision medicine business unit, supporting global pharma and biotech companies deliver on their biomarker strategies. Our global CLIA and CAP accredited laboratories cover Europe, USA and APAC regions. Your global partner for biomarker discovery, development & commercialisation.
Find out more
Galen – Developing and marketing pharmaceuticals globally
Galen – Developing and marketing pharmaceuticals globally
Galen, part of the Almac Group, is a global pharmaceutical company selling medicines worldwide, and partners with like-minded companies to accomplish this.
Find out more
Almac Discovery
Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.
Find out more